Jump to content

Recommended Posts

Have you recently delivered your baby and are you breastfeeding currently?

 

Our research team in the Thrombosis Centre at King’s College Hospital is looking for breastfeeding mothers for a research study aiming to find out whether new oral blood thinning medications pass into human breast milk.

The risk of developing blood clots is increased in women following the birth of a baby. Mothers who are at high risk of getting these clots or already have these clots are given blood thinning medications for at least 7 days after delivery and sometimes for up to 6 weeks.

 

Currently, only traditional blood thinning medicines (heparins and warfarin) can be prescribed to breastfeeding mothers as they are known to be safe during breastfeeding period. Many women find these medicines inconvenient, because they are required to inject heparins themselves at home or attend the clinic frequently for the monitoring of warfarin. In recent years, new blood thinning drugs, such as edoxaban and rivaroxaban, have become available in the UK. They can be taken as tablets and require no monitoring. However, it is not known whether these drugs pass into human breast milk in significant amounts.

 

The purpose of our research study is to investigate whether edoxaban or rivaroxaban pass into human breast milk, which will help to find out if these drugs could be used instead of heparin injections or warfarin for breastfeeding mothers.

 

You may be eligible to participate if you:

• Are breastfeeding currently and,

• Within 8 weeks of delivery

 

Study participation involves:

• Eligibility screening, which can be done at your home

• Taking the blood thinning medication allocated once a day for 3 days and having blood tests and providing breast milk for up to 6 days of the trial.

• Stop breastfeeding your baby for the time you take part in the trial.

 

For this study, we are aiming to recruit 12 women in total.

 

As a way of thanks for participation in the study and for your time, you will receive £300

 

For more information please contact: [email protected] or 07984949011

  • 4 weeks later...

Our team at King's College Hospital are still looking for women who have given birth within the last 8 weeks and breastfeeding and interested to take part in our study.

See attached poster for more details.

Many thanks,

Jignesh

[email protected]

Poster for New Horizons recuritment v2.0 19092022.pdf

  • 3 months later...

Our team at King's College Hospital is still recruiting volunteers who have recently or are expecting their baby and might be interested in our research study.

Please see attached poster for details.

volunteers are given £300 for taking part.

Please contact Jignesh Patel (07984 94 9011 / [email protected]) if interested.

Jignesh Patel

King's College Hospital

Poster for New Horizons recuritment v1.0 05062023 - newborns final.pdf

  • 4 months later...

Our research team at King’s College Hospital is looking for mothers who are up to 3 months post delivery for a research study aiming to find out whether new oral blood thinning medications pass into human breast milk.

The risk of developing blood clots is increased in women following the birth of a baby. Mothers who are at high risk of getting these clots or already have these clots are given blood thinning medications for at least 7 days after delivery and sometimes for up to 6 weeks. 


Currently, only traditional blood thinning medicines (heparins and warfarin) can be prescribed to breastfeeding mothers as they are known to be safe during breastfeeding period. Many women find these medicines inconvenient, because they are required to inject heparins themselves at home or attend the clinic frequently for the monitoring of warfarin. In recent years, new blood thinning drugs, such as edoxaban and rivaroxaban, have become available in the UK. They can be taken as tablets and require no monitoring. However, it is not known whether these drugs pass into human breast milk in significant amounts. 


The purpose of our research study is to investigate whether edoxaban or rivaroxaban pass into human breast milk, which will help to find out if these drugs could be used instead of heparin injections or warfarin for breastfeeding mothers. 

You may be eligible to participate if you: 
• Are breastfeeding currently or able to express breastmilk and,  
• Within 12 weeks of delivery

Study participation involves:
• Eligibility screening, which can be done at your home
• Taking the blood thinning medication allocated once a day for 3 days and having blood tests and providing breastmilk for up to 6 days of the trial.
• Stop breastfeeding your baby for the time you take part in the trial.

For this study, we are aiming to recruit 12 women in total.

As a way of thanks for participation in the study and for your time, you will receive £300

For more information please contact: [email protected] or 07984949011

New Horizons PIL v1.6.pdf

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Latest Discussions

    • Does anyone know when the next SNT meeting is? I am fed up with my son being mugged on East Dulwich Grove! 
    • The issue must be everywhere at the moment. I was visiting a friend last week in Bermondsey, think we were walking  down Linton Rd & we dodged 7 dog poos. It was disgusting. 
    • Thanks for your message — I actually took the time to look into what CityHive does before posting my original comment, and I’d encourage anyone with questions to do the same. Yes, the Companies House filings are overdue — but from what I’ve gathered, this seems likely to be an accountant or admin issue, not some sign of ill intent. A lot of small, community-based organisations face challenges keeping up with formalities, especially when they’re focused on immediate needs like food distribution. Let’s not forget CityHive is a not-for-profit, volunteer-powered CIC — not a corporate machine. As for the directors, people stepping down or being replaced is often about capacity or commitment — which is completely normal in the voluntary and community sector. New directors are sometimes appointed when others can no longer give the time. It doesn’t automatically mean bad governance — it just means people’s circumstances change. CityHive’s actual work speaks volumes. They buy most of the food they distribute — fresh produce, essential groceries, and shelf-stable items — and then deliver it to food banks, soup kitchens, and community projects across London. The food doesn’t stay with CityHive — it goes out to local food hubs, and from there, directly to people who need it most. And while yes, there may be a few paid staff handling logistics or admin, there’s a huge volunteer effort behind the scenes that often goes unseen. Regular people giving their time to drive vans, sort donations, load pallets, pack food parcels — that’s what keeps things running. And when people don’t volunteer? Those same tasks still need to be done — which means they have to be paid for. Otherwise, the whole thing grinds to a halt. As the need grows, organisations like CityHive will inevitably need more support — both in people and funding. But the bigger issue here isn’t one small CIC trying to make ends meet. The real issue is the society we live in — and a government that isn’t playing its part in eradicating poverty. If it were, organisations like CityHive, The Felix Project, City Harvest, FareShare, and the Trussell Trust wouldn’t need to exist, let alone be thriving. They thrive because the need is growing. That’s not a reflection on them — it’s a reflection on a broken system that allows people to go hungry in one of the richest cities in the world. If you're in doubt about what they’re doing, go check their Instagram: @cityhivemedia. You’ll see the real organisations and people receiving food, sharing thanks, and showing how far the impact reaches. Even Southwark Foodbank has received food from CityHive — that alone should speak volumes. So again — how does any of this harm you personally? Why spend time trying to discredit a group trying to support those who are falling through the cracks? We need more people lifting others up — not adding weight to those already carrying the load.
    • Well, this is very disappointing. Malabar Feast  has changed its menu again. The delicious fish curry with sea bass no longer exists. There is now a fish dish with raw mango, which doesn't appeal. I had dal and spinach instead, which was bland (which I suppose I could/should have predicted). One of my visitors had a "vegetable Biriani" which contained hardly any vegetables. Along with it came two extremely tiny pieces of poppadom in a large paper bag.   This was embarrassing, as I had been singing Malabar's praises and recommending we ordered from there. The other mains and the parathas were OK, but I doubt we will be ordering from there again. My granddaughters wisely opted for Yard Sale pizzas, which were fine. Has anybody else had a similar recent poor (or indeed good!)  experience at Malabar Feast?
Home
Events
Sign In

Sign In



Or sign in with one of these services

Search
×
    Search In
×
×
  • Create New...